Barclays
PHVS icon

Barclays’s Pharvaris PHVS Stock Holding History

Barclays’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$123K Buy
4,368
+1,593
+57% +$42.5K ﹤0.01% 3937
2025
Q4 		$77K Buy
+2,775
New +$66.8K ﹤0.01% 4649
2025
Q3 		– Sell
-2,796
Closed -$49.2K – 5674
2025
Q2 		$49.2K Sell
2,796
-65
-2% -$1.05K ﹤0.01% 4711
2025
Q1 		$44.9K Sell
2,861
-3
-0.1% -$51 ﹤0.01% 4639
2024
Q4 		$54.9K Sell
2,864
-2,836
-50% -$58.4K ﹤0.01% 4744
2024
Q3 		$106K Buy
+5,700
New +$104K ﹤0.01% 4560

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Barclays's PHVS Position: Q1 2026 in Review

Barclays increased its Pharvaris (PHVS) stake by 57% in Q1 2026, buying an estimated $42.5K and bringing the position to 4,368 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #3937.

Barclays first reported a position in PHVS in Q3 2024 and has held it in 6 quarters since. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

  • Barclays held 4,368 shares of Pharvaris worth $123K as of Q1 2026.
  • Barclays bought 1,593 Pharvaris shares in Q1 2026, an estimated $42.5K.
  • Pharvaris made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3937 holding.
  • Barclays first reported a position in Pharvaris in Q3 2024 and has held it in 6 quarters since.
  • 110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.